134 related articles for article (PubMed ID: 11367951)
1. [Health policy decisions between rationing and rationalization--exemplified by erythropoietin in tumor anemia].
Wild C; Jonas S
Gesundheitswesen; 2001 Apr; 63(4):221-5. PubMed ID: 11367951
[TBL] [Abstract][Full Text] [Related]
2. [Rationalization versus rationing in surgery].
Nagel E; Meyer zu Vilsendorf A; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():627-31. PubMed ID: 9574225
[TBL] [Abstract][Full Text] [Related]
3. New Zealand cancer patients should have access to erythropoietin treatment.
Carter J; Clay J
N Z Med J; 2006 May; 119(1234):U1989. PubMed ID: 16718300
[TBL] [Abstract][Full Text] [Related]
4. Financial impact of the introduction of erythropoietin in the treatment of anemia of premature infants in Israel.
Dollberg S; Mimouni FB
Isr Med Assoc J; 1999 Oct; 1(2):86-8. PubMed ID: 10731302
[TBL] [Abstract][Full Text] [Related]
5. PHARMAC and erythropoietin for cancer patients.
Grocott R; Metcalfe S; Moodie P
N Z Med J; 2006 Jun; 119(1236):U2039. PubMed ID: 16807581
[No Abstract] [Full Text] [Related]
6. Clinical application of recombinant erythropoietin in anemic cancer patients.
Henry DH
Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
[TBL] [Abstract][Full Text] [Related]
7. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
8. [Performance in the tension field of rationalization and rationing].
Fuchs C
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():764-7. PubMed ID: 9574262
[No Abstract] [Full Text] [Related]
9. Anemia therapy: individual benefit and societal cost.
Denton TA; Diamond GA; Matloff JM; Gray RJ
Semin Oncol; 1994 Apr; 21(2 Suppl 3):29-35. PubMed ID: 8202723
[TBL] [Abstract][Full Text] [Related]
10. [Significance of evidence-based decisions for health policy].
Pientka L
Med Klin (Munich); 1996 Aug; 91(8):541-6. PubMed ID: 8965756
[No Abstract] [Full Text] [Related]
11. [Rationalization, rationing, prioritization: terminology and ethical approaches to the allocation of limited resources in hematology/oncology].
Winkler E
Onkologie; 2011; 34 Suppl 1():2-5. PubMed ID: 21389761
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin: can we afford to use it? Can we afford not to?
Laird J
Transfus Med; 2006 Jun; 16(3):204-5. PubMed ID: 16764600
[TBL] [Abstract][Full Text] [Related]
13. A new approach for assessment of IT programs in health care.
Farcaş DD; Cristea C; Ripanu A; Oprişan M
Stud Health Technol Inform; 1997; 43 Pt B():844-8. PubMed ID: 10179787
[TBL] [Abstract][Full Text] [Related]
14. [Socioeconomic aspects as the limiting factor].
Oberender P
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():632-4. PubMed ID: 9574226
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
Rizzo JD
Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
[TBL] [Abstract][Full Text] [Related]
16. [Cost control in public health by rationing--what are the advantages and disadvantages?].
Mielck A; John J
Gesundheitswesen; 1996 Jan; 58(1):1-9. PubMed ID: 8851125
[TBL] [Abstract][Full Text] [Related]
17. [Rationing in German health care with particular consideration of oncology: view points of German stakeholders--a qualitative interview study].
Lange J; Gönner C; Vollmann J; Rauprich O
Gesundheitswesen; 2015 Jan; 77(1):8-15. PubMed ID: 24696371
[TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness--limits between optimization and rationing].
Ruof J; Schöffski O
Z Rheumatol; 1998 Oct; 57(5):340-4. PubMed ID: 9864843
[TBL] [Abstract][Full Text] [Related]
19. [Economic and ethical aspects of the development of treatment guidelines].
Lauterbach KW
Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):277-82. PubMed ID: 9312433
[TBL] [Abstract][Full Text] [Related]
20. [Rationalization instead of rationing: can GKV have solidarity and efficiency at the same time?].
Rebscher H
Arch Gynecol Obstet; 1995; 257(1-4):733-6. PubMed ID: 8579462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
